JMP Securities believes the manufacturer of an atrial fibrillation device could experience a 70% increase in value.

Shares of medical device provider AtriCure are a lucrative investment opportunity, according to JMP Securities. Analyst Daniel Stauder initiated coverage of the stock with an outperform rating and a price target of $60, suggesting that the shares could increase by almost 70%. Stauder stated that AtriCure is the leading player in treating complex forms of…

Read More

Live updates: Stock futures rise Sunday night as Wall Street anticipates earnings from major tech companies

Stock futures rose on Sunday night as traders awaited the release of corporate earnings from major tech companies. Futures tied to the Dow Jones Industrial Average increased by 0.18%, while S&P 500 futures and Nasdaq 100 futures climbed by 0.23% and 0.15% respectively. These gains came after a challenging week for stocks, with concerns over…

Read More

CEO of Web Summit steps down following apology for remarks about the Israel-Hamas conflict

Paddy Cosgrave, the CEO and co-founder of Web Summit, a highly anticipated annual tech conference, has resigned from his position following controversy surrounding his comments on the Israel-Hamas war. The controversy led to the cancellation of attendance by major tech giants including Alphabet (parent company of Google), Meta (formerly known as Facebook), and Amazon. In…

Read More